MedTech POV Blog

AdvaMed Approves Updated Code of Ethics

  1. Christopher L. White General Counsel & Chief Policy Officer

I am pleased to share that the AdvaMed Board of Directors has approved revisions to the AdvaMed Code of Ethics on Interactions with Health Care Professionals (HCPs) in the U.S., effective June 1, 2022.

The longstanding Code provides important guidance to medical technology companies, and with these revisions, AdvaMed and its members reaffirm their commitment to ethical and compliant interactions and collaborations with HCPs, while also ensuring that the Code reflects the evolving legal, regulatory, and health care landscape.

The revised Code includes updates concerning value-based or outcomes-based health care arrangements, consistent with the recent value-based safe harbor modernizations under the federal Anti-Kickback Statute, as well as revisions and FAQs in response to the OIG’s 2020 Special Fraud Alert on Speaker Programs.

Key Code Updates

In particular, the Code has been revised to:

What’s Next?

In anticipation of the June 1, 2022 effective date, AdvaMed will be developing tools for stakeholders – particularly small companies – to implement these updates.

In addition, AdvaMed is committed to advancing diversity and inclusion, as well as the elimination of health disparities and will be evaluating how the Code can be further revised to address these issues and drive necessary change within the medical technology industry.

MedTech POV Podcast

Subscribe to MedTech POV with Scott Whitaker, a podcast covering the intersection of medtech and policy from every perspective.